Paxlovid Works by Blocking the Enzyme That COVID-19 Needs to Make Copies of Itself Inside Your Body

You've probably heard that Paxlovid (Nirmatrelvir/Ritonavir) is an antiviral for COVID-19 — but what does it actually do once you swallow those pills? How does it fight the virus? And why does it contain two different drugs?

This guide explains Paxlovid's mechanism of action in plain, simple language — no medical degree required.

What Paxlovid Does in Your Body

To understand how Paxlovid works, it helps to know what the COVID-19 virus does when it infects you.

How the Virus Replicates

When the SARS-CoV-2 virus enters your cells, it hijacks your cell's machinery to make copies of itself. Think of it like a burglar breaking into a factory and using the equipment to mass-produce more burglars. A critical step in this process requires a specific viral enzyme — a molecular "scissors" called the main protease (also known as Mpro or 3CLpro). This enzyme cuts long protein chains into the smaller pieces the virus needs to assemble new copies.

How Nirmatrelvir Stops It

Nirmatrelvir, the primary active ingredient in Paxlovid, works by jamming those molecular scissors. It binds to the virus's main protease and blocks it from cutting the protein chains. Without those cuts, the virus can't assemble new copies of itself. It's like gluing the scissors shut — the factory grinds to a halt.

This is why Paxlovid is called a protease inhibitor — it inhibits (blocks) the protease (the cutting enzyme) that the virus depends on.

Why Ritonavir Is Included

Here's where the second ingredient comes in. Ritonavir doesn't directly fight COVID-19. Instead, it's a pharmacokinetic booster — it slows down how quickly your liver breaks down Nirmatrelvir.

Think of it this way: Nirmatrelvir is the fire extinguisher, and Ritonavir makes sure the fire extinguisher stays full long enough to actually put out the fire. Without Ritonavir, your body would metabolize Nirmatrelvir too quickly, and blood levels wouldn't stay high enough to be effective.

Ritonavir does this by blocking an enzyme in your liver called CYP3A4. This is the same reason Paxlovid has so many drug interactions — CYP3A4 is responsible for metabolizing hundreds of other medications too.

How Long Does It Take to Work?

Paxlovid begins working quickly after your first dose. Nirmatrelvir reaches peak blood levels within a few hours of taking it orally.

However, you won't necessarily "feel" it working the way you might feel a pain reliever kick in. What Paxlovid does is slow down viral replication behind the scenes. Clinical studies showed that patients who took Paxlovid within 5 days of symptom onset had an 89% reduction in the risk of hospitalization or death compared to placebo.

The key is starting early — the sooner you take it after symptoms begin, the less virus has been produced, and the more effective the treatment is.

How Long Does It Stay in Your System?

The standard Paxlovid course is 5 days (twice-daily dosing). Nirmatrelvir has a relatively short half-life, which is why the twice-daily dosing with the Ritonavir booster is important to maintain therapeutic levels.

After you complete the 5-day course, both drugs are cleared from your system within a few days. The Ritonavir component's effects on CYP3A4 may linger slightly longer — this is why your doctor may advise waiting a few days before resuming certain medications that were paused during treatment.

Some patients experience what's called "COVID rebound" — a return of symptoms or a positive test after finishing Paxlovid. This is not necessarily a sign of treatment failure. Researchers believe it may be related to an incomplete immune response rather than the drug not working. If symptoms return, contact your doctor.

What Makes Paxlovid Different From Other COVID-19 Treatments?

Several treatments exist for COVID-19, and they work in different ways:

• Paxlovid (Nirmatrelvir/Ritonavir) — Blocks the virus's protease enzyme so it can't replicate. Oral, 5-day course. Most effective option for high-risk outpatients.
• Lagevrio (Molnupiravir) — Works by introducing errors into the virus's genetic code during replication, causing "lethal mutagenesis." Also oral, but clinical trials showed it was less effective than Paxlovid at preventing hospitalization.
• Veklury (Remdesivir) — A different type of antiviral that mimics a building block of RNA, disrupting the virus's ability to copy its genetic material. Requires IV infusion over 3 days, so you need access to an infusion center.
• Monoclonal antibodies — These are lab-made proteins that directly neutralize the virus. However, many previous options have lost effectiveness as COVID-19 variants evolved, and availability has been limited.

Paxlovid's key advantages are that it's taken by mouth at home, has the strongest clinical evidence for reducing hospitalization in high-risk patients, and works against current circulating variants because it targets a viral enzyme (protease) rather than the spike protein that tends to mutate.

For a comparison of treatment options, see our guide to Paxlovid alternatives.

Final Thoughts

Paxlovid's two-drug design is elegant: Nirmatrelvir jams the virus's essential molecular scissors, and Ritonavir makes sure the jam lasts long enough to matter. Together, they give your immune system time to catch up and fight off the infection before it turns severe.

Understanding how your medication works can help you appreciate why timing matters (start within 5 days), why you must complete the full course (5 days, twice daily), and why your doctor needs to know about every other medication you take (because of Ritonavir's effects on your liver enzymes).

If you have a prescription and need to find Paxlovid in stock, Medfinder can help you locate a pharmacy near you.